Jubilant Organosys up on $51 million CRAMS contract

MUMBAI: Jubilant Organosys has signed a long term contract in CRAMS business with a leading US Life Sciences company. The total contract is valued at $51 million. This is take or pay contract with agreed quantities. Further, the company is in discussions to increase the contract to more than 2.5 times.

At 3 pm, the stock was at Rs 358, up Rs 28.65 or 8.70 per cent on the NSE. It touched a high of Rs 365 and low of Rs 330 in trade so far.